Veeva Systems Inc. (LON:0LO3)
London · Delayed Price · Currency is GBP · Price in USD 240.25
-2.36 (-0.97%)
At close: Nov 28, 2025
Veeva Systems Market Cap
Veeva Systems has a market cap or net worth of 29.84 billion as of November 28, 2025. Its market cap has decreased by -0.68% in one year.
Market Cap
29.84B
Enterprise Value
24.89B
Revenue
2.35B
Ranking
n/a
PE Ratio
45.55
Stock Price
240.25
Market Cap Chart
Since October 16, 2013, Veeva Systems's market cap has increased from 2.85B to 29.84B, an increase of 945.83%. That is a compound annual growth rate of 21.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 29.84B | 9.44% |
| Dec 31, 2024 | 27.27B | 12.03% |
| Dec 29, 2023 | 24.34B | 16.71% |
| Dec 30, 2022 | 20.85B | -28.12% |
| Dec 31, 2021 | 29.01B | -3.94% |
| Dec 31, 2020 | 30.20B | 91.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 216.70B |
| GSK plc | 71.96B |
| Haleon | 33.03B |
| Smith & Nephew | 10.64B |
| ConvaTec Group | 4.61B |
| Hikma Pharmaceuticals | 3.44B |
| HUTCHMED (China) | 1.91B |
| Genus | 1.76B |